Trial Profile
Entyvio (vedolizumab) long-term safety study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
- 15 Feb 2016 New trial record